A versatile nanoplatform with excellent biofilm permeability and spatiotemporal ROS regulation for peri-implantitis treatment
Theranostics · 2025
DOI: 10.7150/thno.108830 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Zeyu Han und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Implantology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao 266000, P. R. China. Hauptthemen laut MEDLINE: Peri-Implantitis, Biofilms, Reactive Oxygen Species, Nanoparticles. Die Arbeit wurde bisher 23-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Rationale
Dental implant restoration is essential for rehabilitating dentition defects. However, peri-implantitis (PI) seriously threatens the long-term stability of implants. Treating PI requires the complete eradication of plaque biofilm and the meticulous modulation of inflammatory responses. Antibacterial photodynamic therapy (aPDT) presents a promising potential in the antibacterial realm. Nonetheless, traditional aPDT for PI faces challenges such as inadequate biofilm penetration and distribution of photosensitizers, as well as a lack of precise bacteria targeting. Moreover, the excessive ROS generated by aPDT will aggravate the oxidative stress of peri-implant tissues, and this issue cannot be neglected.
Methods
The CuTA-Por@ε-PL nanoplatforms (CPP NPs) were synthesized and characterized using dynamic light scattering, transmission electron microscopy, and dye probes in detail. The antibacterial and anti-inflammatory activities of CPP NPs were evaluated both in vitro and in vivo. Moreover, the in vivo therapeutic efficacy was successively analyzed through micro-CT, hematoxylin and eosin staining, Masson's staining, immunofluorescence staining, and colony formation units (CFU), among other techniques.
Results
Porphyrin (Por), CuTA nanozyme with SOD/CAT activities, and ε-Polylysine (ε-PL) were combined to fabricate CPP NPs via a straightforward approach. The notable positive charge of CPP NPs facilitated biofilm penetration, distribution and precise bacteria targeting. Then, irradiation with a 660 nm laser triggered a ROS burst for biofilm elimination. After aPDT, CPP NPs scavenged the residual ROS and modulated host immunity by regulating macrophage polarization. As a result, CPP-treated groups demonstrated the most outstanding antibacterial and anti-inflammatory performance in the rat PI model.
Conclusions
Given the pathogenesis of PI, this strategy rationally designed a multifunctional NP with antibacterial and anti-inflammatory functions via spatiotemporal ROS regulation. It provides a potentially novel approach for PI treatment, which may have a profound impact on improving the prognosis of patients with PI and advancing the field of implant dentistry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Implantology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao 266000, P. R. China.
- School of Stomatology, Qingdao University, Qingdao 266000, P. R. China.
- Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao 266021, P. R. China.
Zitieren
APA
Han, Z., Li, Y., Zhan, X., Sun, M., Liang, Y., Yuan, M., Sun, Y., Cao, J., Zhao, B., & Li, F. (2025). A versatile nanoplatform with excellent biofilm permeability and spatiotemporal ROS regulation for peri-implantitis treatment. Theranostics. https://doi.org/10.7150/thno.108830
Vancouver
Han Z, Li Y, Zhan X, Sun M, Liang Y, Yuan M, et al. A versatile nanoplatform with excellent biofilm permeability and spatiotemporal ROS regulation for peri-implantitis treatment. Theranostics. 2025. doi:10.7150/thno.108830
BibTeX
@article{Han2025,
author = {Han, Zeyu and Li, Ying and Zhan, Xin and Sun, Ming and Liang, Yan and Yuan, Mujie and Sun, Yong and Cao, Jie and Zhao, Baodong and Li, Fan},
title = {A versatile nanoplatform with excellent biofilm permeability and spatiotemporal ROS regulation for peri-implantitis treatment},
journal = {Theranostics},
year = {2025},
doi = {10.7150/thno.108830}
}
EUVIMED